Feb 15, 2022 / 01:15PM GMT
Operator
Greetings, and welcome to the Allakos Investor Day. (Operator Instructions) As a reminder, this conference is being recorded. I'll now turn the conference over to Mr. Robert Alexander, CEO.
Mr. Alexander, you may now begin your presentation.
Robert Alexander - Allakos Inc. - CEO & Director
All right. Thank you. Good morning, everyone, and thank you for joining the call.
Before we begin, a reminder that we will be making forward-looking statements, so please refer to our filings with the SEC. With me here today are Craig Paterson, our Chief Medical Officer; Baird Radford, our CFO; Brad Youngblood, our Head of Research; and Adam Tomasi, our President and COO.
As for the agenda, we -- following my introductory remarks, Craig will go through our KRYPTOS and ENIGMA studies. We'll then be joined by Dr. Evan Dellon, to give his perspective on the EGID space and specifically these 2 clinical studies. I will then go through the scientific rationale for our programs with lirentelimab and atopic derm and chronic spontaneous urticaria.
Allakos Inc Investor Day Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers